Clinical Trials Directory

Trials / Completed

CompletedNCT05500690

Understanding Effects of Folic Acid on the Methylosome and Transcriptome of Women With Spina Bifida Affected Pregnancies

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Folic acid is currently considered to be the standard of care for primary and secondary prevention of spina bifida, but the mechanisms underlying folic acid's benefits are unknown. One hypothesis is that folic acid changes DNA methylation and transcription of genes important in neural tube closure. In this study, the investigators will evaluate how DNA methylation of genes associated with neural tube closure changes after a short course of standard-of-care folic acid supplementation. In addition, the investigators will assess whether environmental arsenic exposure modifies the effects of folic acid on the methylosome.

Detailed description

The investigators will encourage women who have recently had a pregnancy affected by spina bifida to take daily folic acid supplements for three months. Folic acid supplementation is considered standard of care for primary and secondary prevention of spina bifida. The investigators will compare DNA methylation in blood and folate levels before and after folic acid use.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFolic Acid Tablet5 mg folic acid supplement

Timeline

Start date
2023-10-15
Primary completion
2024-12-04
Completion
2025-12-01
First posted
2022-08-15
Last updated
2026-03-17

Locations

1 site across 1 country: Bangladesh

Source: ClinicalTrials.gov record NCT05500690. Inclusion in this directory is not an endorsement.